Kenneth Ngo

7PUBLICATIONS
110CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 10, 2026
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK.

|May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion.

|May 02, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer.

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

|Sep 13, 2021
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.

Pınar Özden Eser, Raymond M Paranal, Jieun Son

Pageof 2

Frequent Collaborators

6 joint publications

Prafulla C Gokhale

4 joint publications

Pasi A Jänne

3 joint publications

Cloud P Paweletz

2 joint publications

Elliott J Brea